Spironolactone plus full-dose ACE inhibition in patients with idiopathic membranous nephropathy and nephrotic syndrome: Does it really work?

Paolo Cravedi, Varusca Brusegan, Piero Ruggenenti, Ruth Campbell, Giuseppe Remuzzi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Spironolactone plus full-dose ACE inhibition in patients with idiopathic membranous nephropathy and nephrotic syndrome: Does it really work?'. Together they form a unique fingerprint.

Medicine & Life Sciences